Brandinium

Trademark search for:

RANVYSO

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2019-12-18 — Application filed
  • 2020-02-13 — Sn assigned for sect 66a appl from ib
  • 2020-02-14 — Application filed
  • 2020-02-18 — Application filed
  • 2020-03-02 — Assigned to examiner
  • 2020-03-03 — Final disposition recorded
  • 2020-03-04 — Office action issued
  • 2020-03-24 — Office action issued
  • 2020-03-24 — Office action issued
  • 2020-04-10 — Office action issued
  • 2020-05-22 — Limitation of goods received from ib
  • 2020-07-27 — Attorney/dom.rep.revoked and/or appointed
  • 2020-07-27 — Teas change of domestic representatives address
  • 2020-07-27 — Teas change of owner address received
  • 2020-07-27 — Teas change of correspondence received
  • 2020-07-27 — Applicant/correspondence changes (non-responsive) entered
  • 2020-07-27 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-09-18 — Teas/email correspondence entered
  • 2020-09-18 — Office action issued
  • 2020-09-18 — Correspondence received in law office
  • 2020-09-23 — Office action issued
  • 2020-09-23 — Office action issued
  • 2020-09-23 — Office action issued
  • 2020-10-20 — Limitation from the ib examined, no action is needed
  • 2021-03-23 — Attorney/dom.rep.revoked and/or appointed
  • 2021-03-23 — Teas change of domestic representatives address
  • 2021-03-23 — Teas request for reconsideration received
  • 2021-03-23 — Exparte appeal received at ttab
  • 2021-03-23 — Jurisdiction restored to examining attorney
  • 2021-03-23 — Teas change of correspondence received
  • 2021-03-23 — Ex parte appeal-instituted
  • 2021-03-23 — Teas revoke/app/change addr of atty/dom rep received
  • 2021-03-26 — Approved for pub - principal register
  • 2021-03-26 — Teas/email correspondence entered
  • 2021-03-26 — Assigned to lie
  • 2021-03-26 — Correspondence received in law office
  • 2021-03-27 — Exparte appeal terminated
  • 2021-04-14 — Notification of possible opposition sent to ib
  • 2021-04-14 — Notification of notice of publication e-mailed
  • 2021-04-14 — Notice of start of opposition period created, to be sent to ib
  • 2021-05-02 — Notification processed by ib
  • 2021-05-04 — Published for opposition
  • 2021-05-04 — Official gazette publication confirmation e-mailed
  • 2021-06-04 — New representative at ib received
  • 2021-07-14 — Notification of possible opposition sent to ib
  • 2021-07-14 — Notification of possible opposition created, to be sent to ib
  • 2021-07-20 — Registered-principal register
  • 2021-07-31 — Notification of possible opposition - processed by ib
  • 2021-10-20 — Final disposition recorded
  • 2021-11-26 — Final disposition recorded
  • 2021-11-27 — Final disposition recorded
  • 2021-12-19 — Final disposition recorded
  • 2022-12-03 — Limitation of goods received from ib
  • 2023-01-09 — Assigned to paralegal
  • 2023-02-03 — Notification of effect of cancellation of intl reg e-mailed
  • 2023-02-03 — Limitation from the ib examined and entered
  • 2023-02-10 — Final status recorded

Owner Information

STADA Arzneimittel AG
DE
STADA Arzneimittel AG
DE
STADA Arzneimittel AG
DE

Correspondent

Philip R. Zender SQUIRE PATTON BOGGS (US) LLP
275 Battery Street, Suite 2600
San Francisco, CA 94111
UNITED STATES

Filing Details

Filing Date:
2019-12-18
Status Date:
2023-02-10
Category:
Pharmaceuticals
Filing Year:
2019

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.